feed,title,long_url,short_url
Benzinga,Sanofi In-Licenses Pompe Disease Therapy From Privately-Held Maze Therapeutics For $150M Upfront,https://benzinga.com/general/biotech/23/05/32113267/sanofi-in-licenses-pompe-disease-therapy-from-privately-held-maze-therapeutics-for-150m-upfront,https://da.gd/nJ47V
Benzinga,Astellas Pharma Acquires Iveric Bio For $5.9B To Focus On 'Blindness & Regeneration',https://benzinga.com/general/biotech/23/05/32112605/astellas-pharma-acquires-iveric-bio-for-5-9b-to-focus-on-blindness-regeneration,https://da.gd/CPbNUo
